Equifax
EFX NYSE Research & Consulting Services Financials FY2016βFY2025
Equifax's revenue rose 6.9% to $6.1 billion in fiscal 2025. Its operating margin was 18.0%, down from 18.3% a year earlier. Free cash flow was $1.1 billion, up 39.5%. It paid out $1.2 billion in dividends and buybacks, 102% of free cash flow. The diluted share count fell 0.6%.
What Equifax does
No business description yet.
- Legal name
- EQUIFAX INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000033185-26-000010
0000033185
Revenue and margins
Equifax had $6.1B of revenue in fiscal 2025, up 6.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 3.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 18.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Equifax returned $1.2B to shareholders in fiscal 2025, 102% of free cash flow. The diluted share count fell 0.6%.
Value Equifax yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.9B and divides by 124.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 29.5x Β· peers 18.9x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Equifax can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $225M | $285M | $217M | $170M | $181M |
| Debt incl. finance leases | $5.3B | $5.8B | $5.7B | $5.0B | $5.1B |
| Net debt / EBITDA | 3.1x | 3.4x | 3.6x | 2.8x | 2.7x |
| Debt / equity | 1.5x | 1.5x | 1.3x | 1.1x | 1.1x |
| Interest coverage | 7.8x | 5.8x | 3.9x | 4.6x | 5.2x |
| Current ratio | 0.5x | 0.7x | 0.7x | 0.8x | 0.6x |
| Quick ratio | 0.5x | 0.7x | 0.7x | 0.8x | 0.6x |
| Total assets | $11.0B | $11.5B | $12.3B | $11.8B | $11.9B |
| Total liabilities | $7.4B | $7.6B | $7.6B | $6.8B | $7.1B |
| Shareholders' equity | $3.6B | $4.0B | $4.5B | $4.8B | $4.6B |
| Net debt (β = net cash) | $5.1B | $5.5B | $5.5B | $4.9B | $4.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.5M
1 insider
Sold, 12 months
$25.9M
4 insiders
Of sales under plans
100%
$25.9M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | John W Gamble JrEVP, CFO & COO | Sold plan | 4,500 | $187.96 | $0.8M | Form 4 |
| Jul 24, 2026 | Mark W BegorCEO, Director | Sold plan | 37,791 | $172.16 | $6.5M | Form 4 |
| May 7, 2026 | Chad M BortonEVP, Pres Workforce Solutions | Sold plan | 2,455 | $173.89 | $0.4M | Form 4 |
| May 1, 2026 | John W Gamble JrEVP, CFO & COO | Sold plan | 3,500 | $176.54 | $0.6M | Form 4 |
| Apr 24, 2026 | Mark W BegorCEO, Director | Sold plan | 37,791 | $172.40 | $6.5M | Form 4 |
| Feb 23, 2026 | John W Gamble JrEVP, CFO & COO | Sold plan | 4,500 | $195.72 | $0.9M | Form 4 |
| Feb 18, 2026 | Cecilia MaoEVP, Chief Product Officer | Bought plan | 2,400 | $193.72 | $0.5M | Form 4 |
| Feb 12, 2026 | Chad M BortonEVP, Pres Workforce Solutions | Sold plan | 2,535 | $191.50 | $0.5M | Form 4 |
| Feb 11, 2026 | Jamil FarshchiEVP, Chief Technology Officer | Sold plan | 1,167 | $199.87 | $0.2M | Form 4 |
| Feb 10, 2026 | Jamil FarshchiEVP, Chief Technology Officer | Sold plan | 6,213 | $195.81 | $1.2M | Form 4 |
| Feb 10, 2026 | Mark W BegorCEO, Director | Sold plan | 37,791 | $201.89 | $7.6M | Form 4 |
| Nov 20, 2025 | John W Gamble JrEVP, CFO & COO | Sold plan | 2,500 | $208.37 | $0.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 8 | 7 / 8 | 6 / 8 |
| Accruals ratio | β4.8% | β6.0% | β8.1% |
| Altman Z'' | 2.28 | 2.75 | 2.56 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Equifax EFX | $21.5B | 6.9% | 18.0% | 18.7% | 8.5% | 29.5x | 6 | |
| Thomson Reuters TRI | $55.4B | 3.0% | 28.5% | 27.0% | 11.8% | β | 6 | Compare β |
| TransUnion TRU | $15.8B | 9.4% | 18.7% | 14.5% | 7.1% | 22.6x | 8 | Compare β |
| FTI Consulting FCN | $4.6B | 2.4% | 10.3% | 2.5% | 16.6% | 18.9x | 4 | Compare β |
| Booz Allen Hamilton BAH | $9.4B | β6.4% | 9.2% | 8.5% | 24.2% | 12.2x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.1B | $3.4B | $3.4B | $3.5B | $4.1B | $4.9B | $5.1B | $5.3B | $5.7B | $6.1B |
| Gross profit | $2.0B | $2.2B | β | β | β | β | β | β | β | β |
| Operating income | $825M | $832M | $448M | β$335M | $677M | $1.1B | $1.1B | $934M | $1.0B | $1.1B |
| Interest expense | $92.1M | $92.8M | $104M | $112M | $142M | $146M | $183M | $241M | $229M | $212M |
| Pretax income | $728M | $747M | $370M | β$414M | $685M | $949M | $930M | $718M | $811M | $895M |
| Income tax | $233M | $149M | $53.4M | β$35.7M | $159M | $201M | $230M | $166M | $203M | $231M |
| Net income | $489M | $587M | $311M | β$384M | $520M | $744M | $696M | $545M | $604M | $660M |
| Diluted EPS | $4.04 | $4.83 | $2.56 | β$3.15 | $4.24 | $6.02 | $5.65 | $4.40 | $4.84 | $5.32 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $823M | $816M | $672M | $314M | $946M | $1.3B | $757M | $1.1B | $1.3B | $1.6B |
| Capital expenditure | $174M | $218M | $322M | $400M | $421M | $469M | $625M | $601M | $512M | $481M |
| Free cash flow | $650M | $598M | $350M | β$85.8M | $525M | $866M | $133M | $516M | $813M | $1.1B |
| Depreciation and amortization | $269M | $291M | $316M | $337M | $399M | $490M | $569M | $620M | $681M | $727M |
| Stock-based compensation | $37.1M | $38.3M | $42.5M | $49.7M | $54.7M | $54.9M | $62.6M | $71.8M | $81.6M | $78.4M |
| Acquisitions | $1.8B | $140M | $138M | $273M | $61.4M | $2.9B | $434M | $284M | $0.0M | $74.1M |
| Share buybacks | $0.0M | $77.1M | $0.0M | $0.0M | $0.0M | $69.9M | $0.0M | $0.0M | $0.0M | $928M |
| Dividends paid | $158M | $187M | $188M | $189M | $190M | $190M | $191M | $192M | $193M | $233M |
| Dividends and buybacks | $158M | $265M | $188M | $189M | $190M | $260M | $191M | $192M | $193M | $1.2B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $129M | $336M | $224M | $401M | $1.7B | $225M | $285M | $217M | $170M | $181M |
| Total debt | $2.7B | $2.7B | $2.7B | $3.4B | $4.4B | $5.3B | $5.8B | $5.7B | $5.0B | $5.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $673M | $998M | $902M | $1.2B | $2.5B | $1.1B | $1.4B | $1.4B | $1.4B | $1.4B |
| Current liabilities | $1.3B | $1.7B | $827M | $1.4B | $2.5B | $2.3B | $2.0B | $2.0B | $1.8B | $2.3B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $467M | $567M | $765M | $948M | $1.1B | $1.3B | $1.6B | $1.8B | $1.9B | $1.9B |
| Total assets | $6.7B | $7.2B | $7.2B | $7.9B | $9.6B | $11.0B | $11.5B | $12.3B | $11.8B | $11.9B |
| Total liabilities | $3.9B | $4.0B | $4.0B | $5.3B | $6.4B | $7.4B | $7.6B | $7.6B | $6.8B | $7.1B |
| Shareholders' equity | $2.7B | $3.2B | $3.1B | $2.6B | $3.2B | $3.6B | $4.0B | $4.5B | $4.8B | $4.6B |
| Margins | ||||||||||
| Gross margin | 64.6% | 64.0% | β | β | β | β | β | β | β | β |
| Operating margin | 26.2% | 24.7% | 13.1% | β9.6% | 16.4% | 23.1% | 20.6% | 17.7% | 18.3% | 18.0% |
| EBITDA margin | 34.8% | 33.4% | 22.4% | 0.1% | 26.1% | 33.1% | 31.7% | 29.5% | 30.3% | 30.0% |
| Net margin | 15.5% | 17.5% | 9.1% | β11.0% | 12.6% | 15.1% | 13.6% | 10.4% | 10.6% | 10.9% |
| FCF margin | 20.7% | 17.8% | 10.3% | β2.5% | 12.7% | 17.6% | 2.6% | 9.8% | 14.3% | 18.7% |
| Returns | ||||||||||
| Return on capital | 12.9% | 12.2% | 6.8% | β4.7% | 9.0% | 12.3% | 8.7% | 7.3% | 7.9% | 8.5% |
| Return on capital employed | 17.7% | 15.2% | 7.5% | β5.2% | 9.9% | 14.3% | 11.6% | 9.4% | 10.3% | 11.3% |
| Return on equity | 19.7% | 20.1% | 9.9% | β13.5% | 18.1% | 22.0% | 18.5% | 12.8% | 13.0% | 14.1% |
| Return on assets | 8.8% | 8.5% | 4.3% | β5.1% | 5.9% | 7.2% | 6.2% | 4.6% | 5.0% | 5.6% |
| Growth | ||||||||||
| Revenue growth | β | 6.9% | 1.5% | 2.8% | 17.7% | 19.3% | 4.0% | 2.8% | 7.9% | 6.9% |
| Net income growth | 13.9% | 20.2% | β47.1% | β223.7% | β | 43.1% | β6.5% | β21.7% | 10.8% | 9.3% |
| EPS growth | 13.8% | 19.6% | β47.0% | β223.1% | β | 42.0% | β6.2% | β22.1% | 10.0% | 9.9% |
| FCF growth | 4.3% | β8.0% | β41.4% | β124.5% | β | 65.0% | β84.7% | 288.8% | 57.7% | 39.5% |
| Share count change | 0.2% | 0.3% | β0.1% | 0.5% | 0.7% | 0.7% | β0.2% | 0.5% | 0.8% | β0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 2.1x | 3.2x | 1,579.9x | 2.5x | 3.1x | 3.4x | 3.6x | 2.8x | 2.7x |
| Debt / equity | 1.0x | 0.9x | 0.9x | 1.3x | 1.4x | 1.5x | 1.5x | 1.3x | 1.1x | 1.1x |
| Interest coverage | 9.0x | 9.0x | 4.3x | β3.0x | 4.8x | 7.8x | 5.8x | 3.9x | 4.6x | 5.2x |
| Current ratio | 0.5x | 0.6x | 1.1x | 0.9x | 1.0x | 0.5x | 0.7x | 0.7x | 0.8x | 0.6x |
| Quick ratio | 0.5x | 0.6x | 1.1x | 0.9x | 1.0x | 0.5x | 0.7x | 0.7x | 0.8x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.5% | 6.5% | 9.4% | 11.4% | 10.2% | 9.5% | 12.2% | 11.4% | 9.0% | 7.9% |
| Stock comp / revenue | 1.2% | 1.1% | 1.3% | 1.4% | 1.3% | 1.1% | 1.2% | 1.4% | 1.4% | 1.3% |
| Payouts / FCF | 24.3% | 44.3% | 53.6% | β | 36.1% | 30.0% | 144.1% | 37.2% | 23.8% | 102.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 3.0 | 6.0 | 4.0 | 6.0 | 4.0 | 7.0 | 6.0 |
| Altman Z'' | 3.0 | 3.1 | 3.5 | 1.7 | 2.4 | 1.9 | 2.3 | 2.3 | 2.8 | 2.6 |
| Accruals ratio | β6.0% | β3.3% | β5.0% | β9.3% | β4.9% | β5.7% | β0.5% | β4.8% | β6.0% | β8.1% |
Source: SEC EDGAR XBRL filings (CIK 0000033185). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.